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Conditional genome engineering in the human malaria pathogen Plasmodium falciparum remains 
highly challenging. Here we describe a strategy for facile and rapid functional analysis of genes using 
an approach based on the Cre/lox system and tailored for organisms with short and few introns. Our 
method allows the conditional, site-specific removal of genomic sequences of essential and non-
essential genes by placing loxP sites into a short synthetic intron to produce a module (loxPint) can be 
placed anywhere in open reading frames without compromising protein expression. When duplicated, 
the loxPint module serves as an intragenic recombineering point that can be used for the fusion of 
gene elements to reporters or the conditional introduction of point mutations. We demonstrate the 
robustness and versatility of the system by targeting the P. falciparum merozoite surface protein 1 gene 
(msp1), which has previously proven refractory to genetic interrogation, and the parasite exported 
kinase FIKK10.1.
Protein function can be conditionally interrogated by systems that allow exogenous control of mRNA abundance, 
stability, protein turnover or localization. While these are useful tools, they often deliver only partial depletion 
of a gene product, leading to outcomes that can be difficult to interpret. Of the tools available to conditionally 
silence a gene, methods that allow conditional DNA deletion are often preferred as these completely remove the 
targeted gene or important parts thereof. One of the most widely used conditional DNA deletion methods relies 
on Cre recombinase-mediated recombination between two 34-nucleotide loxP sequences. To examine gene func-
tion using the Cre/lox method, loxP sites are introduced at positions that either flank an entire gene of interest 
or that lie within introns, allowing Cre-driven deletion of an entire gene or key exon1. Both of these options are 
however not suitable for species such as P. falciparum where few genes have introns and where poor transfection 
efficiency precludes facile introduction of multiple loxP sites. In addition, the P. falciparum genome is highly 
AT-rich (> 80% in intergenic regions) making targeted genome modifications in these regions complicated. 
Finally, currently used conditional genome recombination methods in Plasmodium2,3 do not allow conditional 
domain rearrangements, point mutations, or directed fusion to heterologous sequences such as epitope tags or 
reporters. While a range of important human and animal pathogens such as Trypanosomes, several fungal species 
and model organisms like yeast and Dictyostelium contain few and short introns, no strategy has yet been devel-
oped to rapidly place loxP sites into intronless genes.
To substantially increase the ability to conditionally and rapidly modify genes with the potential for broad use 
in species that contain few introns or many mono-exonic genes, an ideal system would allow: 1) a single trans-
fection step for target-directed gene manipulation; 2) the introduction of “silent” loxP sequences anywhere in the 
genome, including within exon sequences; 3) the conditional rearrangement of specific genetic elements such 
that one stretch of DNA can be rapidly replaced by another for use in domain swapping, introduction of point 
mutations, epitope tagging or to generate a reporter for successful recombination events; and 4) tight temporal 
control of Cre activity that allows rapid recombination rates regardless of the organism used.
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Here we have devised a simple strategy that meets all of the above criteria. We validate its use in the human 
malaria parasite Plasmodium falciparum, an organism that presents many inherent difficulties in genetic mod-
ification. We use a standardized small module (loxPint) that consists of a short, loxP site-containing intron that 
can replace endogenous introns or can be placed in open reading frames of episomes as well as in chromosomal 
genes. If duplicated, the loxPint module is reconstituted after Cre-mediated recombination, enabling the fusion, 
replacement, or specific deletion of flanking genetic elements. To achieve rapid recombination rates we use par-
asite lines stably expressing a chemically-regulated Cre (DiCre)1,2. We demonstrate that this system allows the 
rapid, conditional control and modification of essential and non-essential genes alike.
Results
Introduction of silent loxP sites using a standardized intron. Limitations of novel genetic tools in 
P. falciparum are mainly dictated by its low transfection efficiency. For that reason, facile application of the Cre/
lox system2, while introducing a tightly controllable conditional genetic system into the parasite, has been ham-
pered by the fact that flanking target genes with loxP sites can take many months. Such manipulations also carry 
the risk that introduction of loxP sites into flanking regulatory sequences can interfere with gene expression 
levels. In other organisms, loxP sites are commonly placed in introns where they are unlikely to interfere with 
promoter function. However, introns are rare in the P. falciparum genome (45.5% of all protein coding genes are 
single-exon genes, 24.0% contain 2 exons and only 30.5% contain 3 or more exons) (www.plasmoDB.org), which 
limits the use of that strategy. We reasoned that placement of loxP sites into a small intron that naturally occurs 
in the P. falciparum genome might allow it to be used as a universal module that could be placed into exons, 
enabling the flanking of critical segments of genes with silent loxP sites in a single transfection step. Ideally this 
intron would be short and lack long repetitive A or T stretches because these often cause substantial problems 
with gene synthesis. We screened the P. falciparum genome and identified an intron of the sera2 gene (PlasmoDB 
ID PF3D7_0207900) which meets these criteria. To test whether the sera2 intron can accommodate a loxP site, 
we generated a proof-of-principle episomal expression construct, pRex2:loxPint:gfp, in which the intron of rex2 
was replaced with the sera2 intron containing an integral loxP site (loxPint, sequence shown in supplemental 
table 2) and then fused in frame with the green fluorescent protein gene (gfp) (Fig. 1a). We chose REX2 because 
of its small size and because it has been well characterized as a GFP fusion protein that is efficiently exported 
from the intracellular parasite into the host erythrocyte4. We reasoned this would allow its use as a reporter for 
correct loxPint splicing, even for exported proteins. This is an important property as other conditional methods 
that have been applied in P. falciparum, such as protein degradation systems, are not suitable for the study of 
genes encoding exported or secreted proteins5. A second loxPint module was placed downstream of the gfp open 
reading frame, followed by a myc epitope tag sequence. Cre-mediated recombination between the two loxP sites 
was predicted to reconstitute the loxPint module, excising the C-terminal region of REX2 and the entire GFP 
sequence, replacing this sequence with that encoding the myc epitope tag. Activation of Cre recombinase activity 
in the 1G5DC P. falciparum clone is induced by rapamycin (RAP), which mediates rapid heterodimerisation 
of the constitutively-expressed DiCre polypeptides2. This was predicted to lead to recombination between the 
two loxP sites and excision of the 3′ end of rex2 and gfp (Fig. 1a). We transfected pRex2:loxPint:gfp into 1G5DC 
parasites and confirmed faithful expression and localization of REX2.GFP (Fig. 1b). To test whether loxPint was 
correctly spliced in transfected parasite lines, we analysed plasmid DNA (pDNA) and reverse transcribed DNA 
(cDNA) of rex2:loxPint:gfp parasites. Two species were amplified from cDNA, one likely corresponding to the 
spliced variant, and one slightly higher running band that suggested incomplete splicing of the loxPint. Sanger 
sequencing confirmed that the lower band corresponded to the correctly spliced version of rex2:loxPint:gfp and 
verified correct retention of the loxPint following splicing (Fig. 1c). These results showed that the loxPint module 
allows functional splicing in a heterologous locus.
The loxPint module allows conditional domain fusions in an episomal context. To test for correct 
DiCre-mediated recombination between the two loxPint sequences in pRex2:loxPint:gfp, we treated transfected 
parasites with RAP for 4 h then analysed excision between the two loxPint modules by evaluating GFP expression. 
As expected, RAP-treated but not control parasites, showed near complete loss of GFP expression as measured by 
live microscopy (Fig. 1d) and Western Blot (Fig. 1e). To test whether RAP treatment had reconstituted the loxPint 
module in a form that was still correctly spliced, we examined the parasites by immunofluorescence analysis (IFA) 
with anti-myc antibodies. Unfortunately, we could not confirm a specific signal in RAP-treated parasites because 
the anti-myc antibodies cross-reacted strongly with other parasite antigens on IFA and the truncated REX2:myc 
protein was likely too small to be detected on Western blot. However, sequencing of cDNA from the RAP-treated 
parasites confirmed correct splicing of the reconstituted loxPint module, effectively fusing the myc tag in frame 
with the 3′ end of the remaining rex2 open reading frame (Fig. 1f). This shows that duplication of the loxPint 
module allows directed, conditional fusion of distinct protein-coding sequences.
The loxPint module can be used in an endogenous genomic locus and is quantitatively 
spliced. Encouraged by these results, we decided to further validate our method by attempting to introduce a 
loxPint module into the open reading frame of a chromosomal parasite gene with the aim to tag the gene of inter-
est in the same gene modification step as the introduction of two repeated loxPints. For this we chose to investi-
gate the gene encoding an uncharacterized parasite kinase called FIKK10.1 (PF3D7_1016400) that is predicted to 
be exported into the host cell6. The fikk10.1 gene includes two short introns close to its 5′ and 3′ ends and encodes 
a protein with a C-terminal kinase domain, allowing targeting by 3′ replacement. We generated a targeting con-
struct, pfikk10.1:loxPint:HA, designed to introduce a recodonised fikk10.1 kinase domain into the endogenous 
locus flanked by loxPint modules (Fig. 2a) and transfected this construct into 1G5DC parasites. Integration of 
pfikk10.1:loxPint:HA was expected to result in expression of an HA-tagged chimeric FIKK10.1 under the control 
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Figure 1. A loxP containing synthetic intron loxPint allows inducible, targeted DNA rearrangement.  
(a) Schematic shows the loxPint module in the rex2 gene (black rectangle represents the native transmembrane 
domain). Stop codons are represented as yellow hexagons. A second loxPint is located downstream of the 
GFP coding sequence followed by a myc epitope coding sequence. Rapamycin treatment causes dimerization 
of two Cre-recombinase subunits in the DiCre-expressing 1G5DC P. falciparum line. Cre-driven LoxP-site 
recombination between the loxPint modules reconstitutes loxPint and places the myc coding sequence in 
frame with rex2. (b) Live fluorescence image showing pRex2:loxPint:GFP confirms Rex2.GFP expression and 
correct targeting to the host cell. (c) LoxPint is appropriately spliced. The chromatogram shows the nucleotides 
identified in sequencing reactions from cDNA from Rex2:loxPint:GFP parasites. Black box represents exon-
exon boundaries. The resulting amino acid translation is shown in light grey. LoxPint is absent from sequenced 
cDNA and the correct rex2 coding sequence is present, confirming correct splicing. (d) RAP-induced Cre-
mediated DNA excision reduces Rex2.GFP expression. GFP positive parasites are reduced by 97.6% (+ /− 1.1%) 
upon rapamycin treatment (error bars are SD). (e) Western blot showing RAP-induced DNA excision results 
in the loss of Rex2.GFP expression. (f) LoxPint is reconstituted and correctly spliced after Cre-mediated 
recombination. Schematic shows the pRex2:loxPint:GFP construct after Cre-mediated excision before (pDNA) 
and after (cDNA) splicing. The 5′ rex2 sequence that remains after Cre-driven DNA excision is transcribed 
in-frame with the myc epitope coding sequence as shown by cDNA sequencing. The black box in the 
chromatogram highlights the exon-exon boundary.
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Figure 2. Use of the loxPint strategy allows the silent targeting of the exported kinase FIKK10.1 and 
conditional domain fusion. (a) Overview of the strategy to introduce two loxPint modules in a single 
transfection step using single homologous recombination at the 3′ end of FIKK10.1. (b) Schematic of the 
structure of the FIKK10.1 locus after integration of construct pfikk10.1:loxPint:HA, which introduces loxPint 
upstream of a recodonized FIKK10.1 kinase domain. The loxPint is duplicated downstream of an HA3 epitope 
tag sequence to allow removal of the HA3-tagged FIKK10.1 kinase domain by Cre-driven DNA excision. 
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of its endogenous promotor (Fig. 2b). Correct integration of the construct and expression of the modified gene 
was confirmed by PCR, IFA, and Western Blot (Fig. 2b–d). As predicted, treatment of this engineered parasite line 
with RAP led to recombination between the loxPint modules flanking the recodonized fikk10.1 kinase domain 
and subsequent loss of the entire kinase domain and HA tag (amino acid residues 251–641 of FIKK10.1.HA 
(Fig. 2c,d)). Sequencing of cDNA from DMSO-treated control and RAP-treated parasites confirmed correct splic-
ing of the loxPint both before and after DiCre-driven DNA rearrangement (Fig. 2e). Because we had observed 
incomplete splicing from the episomally expressed rex2:loxPint:gfp we tested splicing efficiency of the loxPint in 
the context of the fikk10.1 locus. A single PCR product was obtained from gDNA and cDNA, corresponding to 
the unspliced and spliced versions respectively, indicating complete splicing of the loxPint (Fig. 2e).
To further verify the use of the loxPint module for conditional domain fusions we generated the parasite line 
FIKK10.1:loxPint:HA:GFP which shares all the features of FIKK10.1:loxPint:HA except that RAP treatment leads 
to fusion of the first 250 amino acids of FIKK10.1 with GFP. As expected, treatment of this parasite line with 
RAP led to replacement of the kinase domain of FIKK10.1 with GFP (Fig. 2f). No effects on parasite growth were 
observed after RAP treatment, indicating that FIKK10.1 is likely a non-essential kinase under the conditions 
tested here and further work will be required to identify the biological function of FIKK10.1. However, collec-
tively these data show that the loxPint module can serve as a recombination point for rapid, efficient conditional 
deletion or fusion of DNA elements.
The loxPint module can be placed in essential genes and does not compromise expression 
levels. To test the effectiveness of the loxPint in the modification of a proven essential genomic gene we tested 
its utility in modification of the single exon gene encoding merozoite surface protein-17 (msp1, PlasmoDB ID 
PF3D7_0930300). Using single-crossover homologous recombination, a loxPint module was incorporated into 
the msp1 coding sequence upstream of the glycosyl phosphatidyl inositol (GPI) anchoring signal that tethers 
this protein to the surface of the merozoite, the invasive blood-stage form of the parasite. In the same gene mod-
ification step, a second loxP site was introduced downstream of the msp1 stop codon (Fig. 3a). Excision of the 
loxP-flanked sequence was predicted to produce a truncated form of MSP1 lacking its C-terminus and GPI anchor 
(amino acid residues 1277–1720). The construct readily integrated into the endogenous msp1 locus of transfected 
1G5DC parasites (Fig. 3a). This was confirmed by IFA and Western blot analysis (Fig. 3c,d). RAP-treatment 
of the engineered parasites resulted in the expected deletion of the MSP1 C-terminal domain and GPI anchor 
(Fig. 3b), as confirmed using monoclonal antibodies specific for the deleted C-terminal region of the protein 
(Fig. 3c,d). As we recently reported, RAP treated parasites showed a severe defect in egress from the host eryth-
rocyte8. In tests designed to assess the splicing efficiency of the msp1 gene containing the loxPint, a single ~600 bp 
band corresponding to completely spliced transcript was amplified from cDNA, showing complete splicing of the 
transcript (Fig. 3e). This was confirmed by Sanger sequencing (data not shown). To test that overall expression 
levels of MSP1 were not compromised by the introduction of the loxPint module, we analysed parental 1G5DC 
and MSP1_loxPint parasites by Western blot using monoclonal antibodies specific for MSP1. This detected no 
significant alterations in MSP1 expression levels in msp1:loxPint parasites compared to the parental 1G5DC line 
(Fig. 3f). These results confirmed that the loxPint can be readily introduced into open reading frames of essential, 
mono-exonic endogenous genes and is efficiently spliced without impacting on gene expression levels.
Discussion
In this study we have demonstrated that a small, readily synthesised genetic module comprising a loxP site inte-
grated into an intron can be introduced into a range of genomic loci to: (1) replace native introns; (2) inserted 
into genomic exons; and (3) can even be incorporated into non-native recodonised sequences in the malaria 
parasite Plasmodium falciparum. In all cases the module is correctly and efficiently spliced. Compared to cur-
rently employed strategies for conditional gene deletion, our system represents a substantial step forward as it 
allows the conditional fusion and removal of DNA, irrespective of the presence of endogenous introns, in a single 
transfection step. Simultaneous 3′ tagging of a gene in the same modification step as the introduction of loxPint 
modules provides an invaluable tool for the study of uncharacterized genes, as shown for the parasite kinase 
FIKK10.1. In that case loss of the C-terminal HA tag served as a reporter for efficient recombination between 
the two loxPint modules and GFP was used as a positive reporter for efficient recombination. Importantly, the 
ability to exchange one stretch of DNA with another will allow conditional introduction of point mutations in the 
future (see Supplementary Fig. 1). Here we used single cross-over homologous recombination to introduce the 
loxPint module into the P. falciparum genome, but it is worth noting that successful introduction of an artificial 
exon flanked by two loxPint sequences for internal domain deletion has recently been achieved in P. falciparum 
using CRISPR/Cas9 technology9,10 (Emma Sherling, Michael Blackman and Christiaan van Ooij unpublished 
results (see also Supplementary Fig. S1). It is important to stress that while CRIPSR/Cas9 technology allows 
precise insertion of loxPint modules into genomic loci, it does not on its own allow the functional interrogation 
of essential genes.
(c,d) The introduced loxPint does not interfere with FIKK10.1 expression or export to the host erythrocyte as 
shown by IFA and Western Blot. Cre-driven DNA excision induced by treatment with RAP results in loss of 
the FIKK10.1.HA3 signal in IFA and Western Blot. (e) cDNA sequencing results from DMSO and RAP treated 
FIKK10.1 loxPint parasites shows that the loxPint is correctly spliced and RAP treatment leads to reconstitution 
of the loxPint module, allowing conditional domain re-arrangements. PCR results show complete splicing of 
the loxPint in FIKK10.1 in cDNA but not gDNA. (f) Live fluorescence imaging showing GFP expression in the 
DMSO vs. RAP treated pfikk10.1:loxPint:HA:gfp parasite line.
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Figure 3. Use of the loxPint strategy allows the silent targeting of msp1 in P. falciparum. (a) Schematic 
showing the P. falciparum 1G5DC msp1 locus following the introduction of loxPint by homologous 
recombination via a 3′ replacement. To force integration downstream of the loxPint module, recodonized 
MSP1 sequence is used downstream of that module (red). The endogenous C-terminal end is exchanged with 
a polymorphic MSP1 variant specifically recognized by mAb 111.4, thus effectively epitope tagging the gene. 
The modified msp1:loxPint locus is followed by a second loxP site that allows removal of the msp1 3′ coding 
sequence. The msp1 GPI anchor coding sequence is shown in blue. Yellow hexagon represents a stop codon. 
Correct integration of the construct into the endogenous locus is verified by PCR (insert and primer binding 
sites shown in (b)). (b) Cre-driven DNA excision results in the truncation of MSP1 (loss of amino acid residues 
1240–1682, which includes the mAb X509 and mAb 111.4 epitopes). (c) The introduced loxPint is efficiently 
spliced and does not interfere with MSP1 expression or localisation, as shown by normal expression of MSP1 
in control (DMSO-treated) schizonts by IFA. MSP1 was detected by IFA with mAb X509. Cre-driven DNA 
excision induced by treatment with RAP results in loss of the mAb X509 epitope. The rhoptry marker anti-
RhopH2 mAb 61.3 (green)was used as a control. Schizont nuclei are stained with DAPI (blue). Scale bar, 5 μ M.  
(d) Western blot, showing that reactivity with mAb X509 is lost upon RAP-treatment. (e) PCR showing 
complete splicing of the loxPint module in msp1:loxPint in two independent preparations of cDNA. (f) Western 
blot showing that introduction of the loxPint module into the msp1 locus does not alter MSP1 expression 
levels compared to the parent 1G5 parasite line. Excision results in expression of a truncated MSP1 that is still 
recognised by mAb 89.1, which binds an epitope within the N-terminal part of MSP1 (see (b)).
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The ability to conditionally disrupt genes such as FIKK10.1 that are non-essential in cell culture is just as 
important as it is for essential genes. Many genes that are not required during the blood stages in cell culture 
are readily lost. As such, phenotypes associated with gene knock-out studies that aim to interrogate for exam-
ple sexual stage formation, bear a substantial risk of gene loss during the gene modification step. Our strategy, 
which allows the incorporation of 2 loxP sites in a single transfection step and delete a genetic element within 
a single parasite generation (~48 h) in a RAP controlled manner significantly reduces the time that it takes to 
generate such mutants by conventional methods, including CRIPSR/Cas9. The observation that the loxPint 
introduced into the non-essential FIKK10.1 parasite line is quantitatively spliced is important since it shows 
that selective pressure is not required for correct splicing of the loxPint and so it can be used for essential and 
non-essential genes alike. While we did not detect unspliced loxPint in the two genomic loci tested here, the pres-
ence of unspliced product from the REX2:GFP episome indicates that under some circumstances splicing may 
not be 100% efficient. Whether this is due in this case to the mRNA originating from an episome with potentially 
incomplete 5′ and or 3′ regulatory mRNA elements is unknown. However, given that we have shown that the 
loxPint works faithfully in two distinct endogenous loci, we are confident that it will prove a versatile novel tool 
to interrogate the many unknown and known essential and non-essential genes in the human malaria parasite.
The combination of a standardized small intron bearing a loxP site in conjunction with DiCre will open up 
its use to species beyond the malaria parasite where splicing machinery is present. While a strategy has been 
previously developed in mice where a synthetic intron was used to introduce a cassette (conditionals by inversion 
(COIN- module)) this is unlikely to be functional in organisms with fewer and shorter introns11,12 because of its 
large size. In conclusion, the method we present here is a major breakthrough in our ability to study the function 
of essential and non-essential genes in the malaria parasite P. falciparum. Because of the simplicity of its design 
we predict it will prove widely useful.
Materials and Methods
P. falciparum culture and transfection. P. falciparum clone 1G5DC2 and the transfected parasite lines 
established here were cultured as described13. Routine synchronization was by Percoll enrichment and sorbitol 
treatment. For transfection, either purified schizont-stage or ring-stage parasites (> 5% parasitemia) were elec-
troporated with 50–150 ug of plasmid DNA as described2,14–16 and selection was performed with 5 nM WR99210 
(Jacobus Pharmaceuticals). To select for plasmid integration into the fikk10.1 or msp1 locus, transfectants were 
grown in the absence and then presence of 5 nM WR99210 (21 days in the absence of drug followed by growth in 
the presence of drug until a viable parasite population was re-established). Cycling between growth in the absence 
and then presence of WR99210 was performed at least twice. Plasmid integration into the fikk10.1 or msp1 locus 
was verified by PCR using the primers described in Supplementary Table 1. For fikk10.1 modification, integration 
was confirmed after each drug cycle.
To induce DiCre-driven loxP site recombination, synchronized ring-stage parasites were treated with 100 nM 
RAP (Sigma) or DMSO only (final concentration 1% v/v) for 4 h. Parasites were subsequently washed twice with 
warm RPMI and returned to culture. Samples used for nucleic acid extraction were taken at least 24 h after rapa-
mycin treatment, and samples used for immunofluorescence (IFA) or protein extraction were taken at the end of 
the same asexual cycle (~44 h following RAP treatment) or in subsequent cycles.
loxPint design and Construct Assembly. To identify an intron that could be used to silently intro-
duce loxP sequences, we used a combination of manual searching and motif screening (using the search term 
“AGGTAA.{30,120}AGAT” with the PlasmoDB motif search feature, which incorporates bioinformatics analysis of 
P. falciparum 3D7 intron structure performed by Zhang et al.17. This allowed the identification of several short 
intron sequences that could potentially be used to introduce loxP sites. We chose the short intron of sera2 because 
it contained few extended mono-nucleotide tracts and could readily be synthesized by gene synthesis services. 
The 34 nt loxP sequence was inserted into the sera2 intron after identification of its probable branch point17 so that 
splicing would likely proceed correctly even in the presence of these additional nucleotides. See Supplemental 
Table 2 for the complete Sera2Intron:LoxP sequence.
To generate the loxP:intron proof-of-principle construct pRex2:loxPint:gfp, we replaced the Rex2.GFP cassette 
of a pARL-based Rex2.GFP-encoding plasmid4 (a kind gift of Tobias Spielmann, Bernhard Nocht Institute for 
Tropical Medicine, Hamburg, Germany) with a rex2.GFP sequence in which the endogenous rex2 intron was 
replaced with the loxPint sequence. The GFP-coding sequence was followed by a stop codon and a second loxPint, 
all followed by a myc-Tag and stop codon. This sequence was synthesized (Geneart® , see also Supplementary 
Table 2) then amplified using primers Rex2.POP.F and Rex2.POP.R and cloned into KpnI and AvrII-digested 
pARL:rex2GFP using Gibson assembly18.
To generate pMSP1_loxPint, the 998 bp msp1 targeting fragment was amplified from P. falciparum 3D7 
genomic DNA using primers endo3D7-MSP1-BglII-targ-F and endo3D7-MSP1-R. The recodonized frag-
ment was created by amplifying recodonized sequence from plasmid pZ-3D7-MSP138/42 (a kind gift of Dr 
Christian Epp, University of Heidelberg, Germany) using primers syn3D7-MSP1-F and syn3D7-MSP1 + PstI-R. 
The fragments were then joined together by overlapping PCR (using primers endo3D7-MSP1-BglII-targ-F 
and syn3D7-MSP1 + PstI-R) to create a fragment with 5′ BglII and 3′ PstI restriction site overhangs. This was 
ligated into the pHH1-MSP119 backbone, which has the wMSP119 in the 3′ end (created by digesting the plas-
mid pMSP1chimWT19 with BglII and PstI). The resultant plasmid construct was called pHH1-3D7wt. To intro-
duce the loxPint, a ~400 bp sequence corresponding to the loxPint fragment flanked by msp1 targeting sequence 
at the 5′ and 3′ ends (-CCTCAACCAG-loxPint-ATGTAACTCC-; bold letters indicate a naturally occurring 
AGAT motif, which effectively serves as the intron-exon boundary) was synthesised by Geneart® (see also 
Supplementary Table 2) and introduced into pHH1-3D7wt using restriction sites HpaI and BstEII. This generated 
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plasmid pMSP1_loxPint. The plasmid structure was confirmed by nucleotide sequencing on both strands. See 
Supplementary Table 2 for the full recodonized msp1 fragment sequence.
The FIKK10.1 targeting construct was generated by removal of the loxPint in the rex2:loxPint:gfp cassette of 
pRex2:loxPint:gfp using inverse PCR. This also introduced a point mutation into rex2:GFP that prevents REX2.
GFP expression. The resulting plasmid was digested with Not1 to introduce the fikk10.1 homology region and 
recodonized kinase domain by Gibson assembly to generate the plasmid pfikk10.1:loxPint:HA. The fikk10.1 
homology region consists of fikk10.1 nucleotides 1 to 1033 and was amplified using primer FK10.1HRF and 
FK10.1HRR. The recodonized kinase domain corresponds to fikk10.1 nucleotides 1034 to 2319 lacking the 3′ 
native intron. The recodonized kinase domain was synthesized (Geneart® , see also Supplementary Table 2) and 
then amplified using primers FK10.1RCF and FK10.1RCR. The final plasmid was sequenced to confirm correct 
assembly. See Supplementary Table 2 for the full recodonized fikk10.1 kinase domain sequence including the 
added loxPint sequence.
All primers used in this study can be found in Supplementary Table 1.
Immunofluorescence. Live microscopy: Rex2:GFP and FIKK10.1loxPint:GFP expression was quantified 
by imaging live synchronized parasites that had been treated with RAP or DMSO for 4 h in at least the previous 
cycle. Parasites were taken fresh out of cell culture and treated with 4′,6-diamidino-2-phenylindole (DAPI) to 
visualize nuclei. Images were taken using a Ti-E Nikon microscope using a 40x and 100x TIRF objective at room 
temperature equipped with an LED-illumination and an Orca-Flash4 camera. Images were processed with Nikon 
Elements software.
For immunofluorescence of the FIKK10.1loxPint parasite line, air-dried blood films were fixed for 4 min in 
ice-cold methanol and subsequently rehydrated in PBS for 5 min. Slides were blocked in 3% (w/v) bovine serum 
albumin (BSA) in PBS containing kanamycin (50 μ g/ml) for 1 h and subsequently incubated with primary or 
secondary antibodies in 3% (w/v) BSA in PBS containing kanamycin (50 μ g/ml) for 45 min. Antibody concentra-
tions used were: rat anti-HA high affinity (Roche) (1:1000), rabbit anti-MAHRPI ((1:1000) a kind gift of Lindsay 
Parish and Julian Rayner). Images were taken using a Ti-E Nikon microscope using a 100x TIRF objective at room 
temperature equipped with an LED-illumination and an Orca-Flash4 camera. Images were processed with Nikon 
Elements software.
For MSP1 immunofluorescence, thin films of P. falciparum cultures were air dried, fixed in 4% paraformal-
dehyde (in PBS) for 30 min at room temperature and cell membranes permeabilised in 0.1% (v/v) Triton X-100 
(SIGMA) for 10 min. Fixed slides were then washed three times with PBS for 10 min and blocked overnight at 
4 °C in 3% (w/v) BSA in PBS. Slides were probed with anti-MSP1 mAb X50920 using undiluted supernatant from 
culture hybridomas. Slides were also probed with anti-RhopH2 mAb 61.3 (1:250)21. Slides were probed with pri-
mary sera for 30 min at 37 °C and then washed for 10 min in PBS. Slides were then probed with an appropriate 
fluorescent secondary antibody (1:2000) and washed for 10 min with PBS. Slides were stained with DAPI and 
mounted in PBS/glycerol and images collected using AxioVision 3.1 software on an Axioplan 2 Imaging system 
(Zeiss) using a Plan-APOCHROMAT 1006/1.4 oil immersion objective22.
Western Blotting. Western Blotting was performed according to standard methods. Briefly, Rex2.GFP or 
FIKK10.1.HA-expressing parasites were released from erythrocytes by addition of 0.1% (w/v) saponin/PBS for 
5 min at room temperature. 0.1% saponin lysates were centrifuged (> 15000 × G) and the resulting parasite pellet 
was solubilized with 1X sample buffer with 5% beta-mercaptoethanol at a concentration of 2.5–5 × 108 parasites/ml. 
Parasite extracts were subjected to SDS PAGE and transferred onto nitrocellulose membranes. Rex2.GFP was vis-
ualized by probing the blots with rabbit anti-GFP antibodies (Abcam (1:500)) and goat anti-rabbit-HRP (Insight 
Biotechnology (1:4000)). FIKK10.1.HA was visualised using rat anti-HA hi affinity (Roche (1:500)) and goat 
anti-rat-HRP (1:4000 (Sigma)). For detection of MSP1, schizonts were Percoll-enriched according to standard 
methods then solubilized by addition of SDS sample buffer, subjected to SDS PAGE, and proteins transferred 
to nitrocellulose membranes. MSP1 was visualized by probing blots with anti-MSP1 mAb X509 or mAB 89.120 
(undiluted hybridoma culture supernatant) and a goat anti-human-HRP secondary antibody (Sigma). SERA5 
was visualized using polyclonal rabbit anti-SERA5 serum.
Nucleic acid extraction, cDNA synthesis, and sequencing. DNA was extracted from P. falciparum 
parasite lines using the QIAamp DNA Blood MiniKit (Qiagen). RNA was extracted as described23 and DNA was 
removed using the Ambion TURBO DNA-free kit (Applied Biosystems). cDNA was produced from isolated, 
DNAse-treated RNA by first-strand cDNA synthesis using random hexamers (Superscript III cDNA synthesis 
kit, Invitrogen). For sequencing, primers allowing PCR amplification across the LoxPint module both before 
and after DiCre-induced recombination were designed for Rex2, MSP1, and FIKK10.1 and the resulting PCR 
fragment was either sequenced directly or blunt cloned into pCR.Blunt II-TOPO using a Zero Blunt PCR cloning 
kit (Invitrogen).
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